Sort
15,842 grants matching “pancreatic cancer”
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2016 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2020 · CA
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation
$368,224Anna Moore · Massachusetts General Hospital · R01 · FY2011 · DK
The Johns Hopkins Cancer Nanotechnology Training Center
$368,155Denis Wirtz · Johns Hopkins University · R25 · FY2010 · CA
Musashi-mediated control of pancreatic cancer growth and progression
$368,133Tannishtha Reya · University Of California, San Diego · R01 · FY2019 · CA
Mechanisms of cancer cell chemotaxis in perineural invasion
$368,132Richard J Wong · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
ATDC Function in Human Pancreatic Adenocarcinoma
$368,125Diane M Simeone · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
$368,038Rebekah White · University Of California, San Diego · R01 · FY2024 · CA
Vitamin B6 Modulates NK Cell Metabolism in Pancreatic Cancer
$367,975Kamiya Mehla · University Of Oklahoma Hlth Sciences Ctr · R37 · FY2024 · CA
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer
$367,956Hui Mao · Emory University · R01 · FY2013 · CA
CYTOKINE INFLAMMATORY MEDIATORS AND MUCIN REGULATION IN MIDDLE EAR EPITHELIUM
$367,766Joseph E Kerschner · Medical College Of Wisconsin · R01 · FY2007 · DC
PHARMACOLOGICAL MODULATION OF PIEZO1 CHANNELS
$367,686Jerome Jacques Lacroix · Western University Of Health Sciences · R01 · FY2025 · GM
PHARMACOLOGICAL MODULATION OF PIEZO1 CHANNELS
$367,685Jerome Jacques Lacroix · Western University Of Health Sciences · R01 · FY2024 · GM
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
$367,661Ying Yuan · University Of Tx Md Anderson Can Ctr · U24 · FY2024 · CA
A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell System
$367,609Rajib Saha · University Of Nebraska Lincoln · R35 · FY2023 · GM
Normalizing PDAC stroma with PCBP2 siRNA nanoparticles to improve the antitumor activity of chemotherapy and immunotherapy
$367,571Kun Cheng · University Of Missouri Kansas City · R01 · FY2025 · CA
GOLPH3 in vascular smooth muscle cell biology and vascular disease
$367,500Chunxiang Zhang · University Of Alabama At Birmingham · R01 · FY2017 · HL
GOLPH3 in vascular smooth muscle cell biology and vascular disease
$367,500Chunxiang Zhang · University Of Alabama At Birmingham · R01 · FY2016 · HL
GOLPH3 in vascular smooth muscle cell biology and vascular disease
$367,500Gangjian Qin · University Of Alabama At Birmingham · R01 · FY2019 · HL
Transcriptional Elongation Control in Development and Disease
$367,425Ali Shilatifard · Northwestern University At Chicago · R01 · FY2019 · CA
Role of CDK4 in Cell Cycle Progression and Cancer
$367,408E Premkumar Reddy · Temple Univ Of The Commonwealth · R01 · FY2006 · AG
Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis
$367,400Jon Sin · Cedars-Sinai Medical Center · R01 · FY2021 · DK
Tailoring Therapy to Pancreatic Cancer Subtypes
$367,303Eric Collisson · University Of California, San Francisco · R01 · FY2020 · CA
Clinical trial development in cancer vaccines
$367,265Samir Khleif · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Inhibition of CDK5 as a Treatment for Pancreatic Cancer
$367,223Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2018 · CA